Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

124.88
Delayed Data
As of Mar 29
 -0.17 / -0.14%
Today’s Change
89.74
Today|||52-Week Range
132.95
+10.83%
Year-to-Date
No recent news for Abiomed Inc.

Today’s Trading

Previous close125.05
Today’s open124.79
Day’s range124.21 - 125.85
Volume278,875
Average volume (3 months)405,980
Market cap$5.4B
Dividend yield--
Data as of 3:59pm ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+38.56%
Earnings growth (next 5 years)+25.50%
Revenue growth (last year)+43.09%
P/E ratio116.7
Price/Sales12.92
Price/Book14.44

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...+0.21+0.26%
MASIMasimo Corp0.000.00%
NUVANuVasive Inc+0.03+0.04%
DXCMDexCom Inc+1.18+1.40%
Data as of 4:02pm ET, 03/29/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)$0.35
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts


Search for Jobs